Overcoming Metabolic Challenges in the Tumor Microenvironment: Current Solutions

Bogdanov, A., Bogdanov, A., Chubenko, V., Volkov, N., Moiseenko, F., & Moiseyenko, V. (2022). Tumor acidity: From hallmark of cancer to target of treatment. Frontiers in Oncology, 12, 979154. Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023). Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal transduction and targeted therapy, 8(1), 70. Comito, G., Ippolito, L., Chiarugi, P., & Cirri, P. (2020). Nutritional exchanges within tumor microenvironment: impact for cancer aggressiveness. Frontiers in Oncology, 10, 396. Cozene, B., Sadanandan, N., Gonzales-Portillo, B., Saft, M., Cho, J., Park, Y. J., & Borlongan, C. V. (2020). An extra breath of fresh air: hyperbaric oxygenation as a stroke therapeutic. Biomolecules, 10(9), 1279. Elebiyo, T. C., Rotimi, D., Evbuomwan, I. O., Maimako, R. F., Iyobhebhe, M., Ojo, O. A., . . . Adeyemi, O. S. (2022). Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy. Cancer Treatment and Research Communications, 32, Eniafe, J., & Jiang, S. (2021). The functional roles of TCA cycle metabolites in cancer. Oncogene, 40(19), 3351-3363. Fendt, S.-M., Frezza, C., & Erez, A. (2020). Targeting metabolic plasticity and flexibility dynamics for cancer therapy. Cancer discovery, 10(12), 1797-1807. Gambardella, V., Tarazona, N., Cejalvo, J. M., Lombardi, P., Huerta, M., Roselló, S., . . . Cervantes, A. (2020). Personalized medicine: recent progress in cancer therapy. Cancers, 12(4), 1009. Goul, C., Peruzzo, R., & Zoncu, R. (2023). The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nature reviews Molecular cell biology, 24(12), 857-875. Hapke, R. Y., & Haake, S. M. (2020). Hypoxia-induced epithelial to mesenchymal transition in cancer. Cancer letters, 487, 10-20. Huang, C. K., Sun, Y., Lv, L., & Ping, Y. (2022). ENO1 and Cancer. Molecular Therapy- Oncolytics, 24, 288-298. Huang, Y., Sun, G., Sun, X., Li, F., Zhao, L., Zhong, R., & Peng, Y. (2020). The potential of lonidamine in combination with chemotherapy and physical therapy in cancer treatment. Cancers, 12(11), 3332. Jacquet, P., & Stéphanou, A. (2022). Searching for the metabolic signature of cancer: A review from Warburg’s time to now. Biomolecules, 12(10), 1412. Jaworska, M., Szczud?o, J., Pietrzyk, A., Shah, J., Trojan, S. E., Ostrowska, B., & Kocemba- Pilarczyk, K. A. (2023). The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells. Pharmacological Reports, 75(4), 876-890. Keerthana, C. K., Rayginia, T. P., Shifana, S. C., Anto, N. P., Kalimuthu, K., Isakov, N., & Anto, R. J. (2023). The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Frontiers in Immunology, 14, Kocianova, E., Piatrikova, V., & Golias, T. (2022). Revisiting the Warburg effect with focus on lactate. Cancers, 14(24), 6028. Koltai, T. (2022). The complex relationship between multiple drug resistance and the tumor pH gradient: a review. Cancer Drug Resistance, 5(2), 277. Korsakova, L., Krasko, J. A., & Stankevicius, E. (2021). Metabolic-targeted combination therapy with dichloroacetate and metformin suppresses glioblastoma cell line growth in vitro and in vivo. in vivo, 35(1), 341-348. Liu, G. Y., & Sabatini, D. M. (2020). mTOR at the nexus of nutrition, growth, ageing and disease. Nature reviews Molecular cell biology, 21(4), 183-203. Martí i Líndez, A.-A., & Reith, W. (2021). Arginine-dependent immune responses. Cellular and molecular life sciences, 78(13), 5303-5324. Martínez-Reyes, I., & Chandel, N. S. (2021). Cancer metabolism: looking forward. Nature Reviews Cancer, 21(10), 669-680. Mirabile, A., Rivoltini, L., Daveri, E., Vernieri, C., Mele, R., Porcu, L., . . . Cascinu, S. (2020). Metabolism and Immune Modulation in patients with solid tumors: systematic review of preclinical and clinical evidence. Cancers, 12(5), 1153. Moindjie, H., Rodrigues-Ferreira, S., & Nahmias, C. (2021). Mitochondrial metabolism in carcinogenesis and cancer therapy. Cancers, 13(13), 3311. Neophytou, C. M., Panagi, M., Stylianopoulos, T., & Papageorgis, P. (2021). The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities. Cancers, 13(9), 2053. Pan, Y., Liu, L., Mou, X., & Cai, Y. (2023). Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment. ACS nano, 17(21), 20875-20924. Robles-Flores, M., Moreno-Londoño, A. P., & Castañeda-Patlán, M. C. (2021). Signaling pathways involved in nutrient sensing control in cancer stem cells: an overview. Frontiers in Endocrinology, 12, 627745. Safrhansova, L., Hlozkova, K., & Starkova, J. (2022). Targeting amino acid metabolism in cancer. International review of cell and molecular biology, 373, 37-79. Selvakumar, S. C., Preethi, K. A., Ross, K., Tusubira, D., Khan, M. W. A., Mani, P., . . . Sekar, D. (2022). CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer. Molecular cancer, 21(1), 83. Sun, N.-Y., & Yang, M.-H. (2020). Metabolic reprogramming and epithelial-mesenchymal plasticity: opportunities and challenges for cancer therapy. Frontiers in Oncology, 10, Tanabe, A., & Sahara, H. (2020). The metabolic heterogeneity and flexibility of cancer stem cells. Cancers, 12(10), 2780. Tsilingiris, D., Tzeravini, E., Koliaki, C., Dalamaga, M., & Kokkinos, A. (2021). The role of mitochondrial adaptation and metabolic flexibility in the pathophysiology of obesity and insulin resistance: an updated overview. Current Obesity Reports, 10, 191-213. Vaupel, P., & Multhoff, G. (2021). Revisiting the Warburg effect: historical dogma versus current understanding. The Journal of physiology, 599(6), 1745-1757. Wang, B., Zhao, Q., Zhang, Y., Liu, Z., Zheng, Z., Liu, S., . . . Jiang, X. (2021). Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy. Journal of Experimental & Clinical Cancer Research, 40, 1-16. Wang, R. C., & Wang, Z. (2023). Precision medicine: disease subtyping and tailored treatment. Cancers, 15(15), 3837. Zheng, X., Fan, H., Liu, Y., Wei, Z., Li, X., Wang, A., . . . Lu, Y. (2022). Hypoxia boosts aerobic glycolysis in carcinoma: a complex process for tumour development. Current Molecular Pharmacology, 15(3), 487-501. Zhuo, C., Zhang, J., Lee, J.-H., Jiao, J., Cheng, D., Liu, L., . . . Li, M. (2021). Spatiotemporal control of CRISPR/Cas9 gene editing. Signal transduction and targeted therapy, 6(1), Zou, Z., Tao, T., Li, H., & Zhu, X. (2020). mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell & bioscience, 10(1), 31.